{"title":"罕见癌症,继续前进的议程-编辑的特别前言","authors":"D. O’Connor","doi":"10.1080/21678707.2020.1821529","DOIUrl":null,"url":null,"abstract":"Rare cancers affect one in five new patients with cancer and this second special edition highlights some of the continued activity in the field (first special edition[1]). Of note since the first s...","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21678707.2020.1821529","citationCount":"0","resultStr":"{\"title\":\"Rare cancers, the continued agenda for progress – editor’s special foreword\",\"authors\":\"D. O’Connor\",\"doi\":\"10.1080/21678707.2020.1821529\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rare cancers affect one in five new patients with cancer and this second special edition highlights some of the continued activity in the field (first special edition[1]). Of note since the first s...\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2020-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/21678707.2020.1821529\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/21678707.2020.1821529\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21678707.2020.1821529","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rare cancers, the continued agenda for progress – editor’s special foreword
Rare cancers affect one in five new patients with cancer and this second special edition highlights some of the continued activity in the field (first special edition[1]). Of note since the first s...